October 2, 2023
John Lushetsky joins ML Strategies as a Senior Vice President.
April 6, 2021 | ABC News
In an article published by ABC News, Senior Vice President, Strategic Communications of ML Strategies Nancy J. Sterling was quoted on behalf of client the State Police Association of Massachusetts in response to concerns that members are declining to receive the COVID-19 vaccination. Ms. Sterling stated that she has not seen any hesitancy toward the vaccine within the union, and added that many officers may have received the vaccine at other sites, rather than police-designated ones.
March 23, 2021 | The Boston Globe
In an article published by The Boston Globe, Director of Government Relations at ML Strategies Anthony DeMaio was quoted in response to the Senate’s recent confirmation of Boston Mayor Martin J. Walsh as Secretary of the Department of Labor. In addition to pandemic response, Mr. DeMaio emphasized the importance of Walsh working to restore credibility and confidence in the department, particularly in enforcement.
January 5, 2021 | American Health Law Association
Mintz Member M. Daria Niewenhous co-authored an American Health Lawyers Association (AHLA) Business Law and Governance Practice Group Briefing that featured a Q&A discussion with two strategic communications and media experts, including Senior Vice President, Strategic Communications of ML Strategies Nancy J. Sterling, APR, Fellow PRSA, offering insights on best practices for proactive and reactive media communications for healthcare organizations.
January 5, 2021 | Bloomberg Law
Vice President of ML Strategies Christian Fjeld was quoted in an article published by Bloomberg Law on how the Internet of Things Cybersecurity Improvement Act of 2020 may impact the industry due to the government’s purchasing power.
December 8, 2020 | Westlaw
In Thomson Reuters’ Westlaw, Vice President of ML Strategies Christian Fjeld was quoted on the Internet of Things (IoT) Cybersecurity Improvement Act of 2020, which establishes security standards for IoT devices owned or controlled by the federal government and was recently signed into law by President Trump, and its potential “spillover effects” into the private sector.
November 23, 2020 | Inside Health Policy
In an article published by Inside Health Policy, Mintz Member Joanne Hawana and Senior Director of ML Strategies Aaron Josephson commented on calls from industry leaders for the Biden administration to consider making the U.S. Food and Drug Administration (FDA) an independent agency, separate from the U.S. Department of Health and Human Services (HHS), which they assert would be unlikely to move very far in Congress.